Developments in Research on the Relationship Between Matrix Metalloproteinases and Osteoarthritis

LUO Mei, DU Xin-mei, ZHOU Xue-dong

Abstract

Matrix metalloproteinases (MMPs) acquired their names because they depend on metal ions such as Ca2+ and Zn2+ as their cofactors. Members of this family of proteins share a similar structure consisting of five functionally distinct structural domains. MMPs, including MMP-1, MMP-3, MMP-9, and MMP-13, are key substances that promote cartilage matrix degradation and play an important role in the occurrence and progression of osteoarthritis (OA). MMPs boost the development of OA through the degradation of extracellular matrix proteins of chondrocytes, the promotion of inflammation, and other mechanisms, and are hence attracting extensive and increasing attention from the medical community. OA is a common degenerative disease that occurs in the joints and is associated with aging, metabolism, infections, genetics, exercise, and other predisposing factors. The pathological changes it causes can lead to a series of clinical symptoms such as joint pain, morning stiffness, and restricted joint movement, severely affecting patients' quality of life. The pathogenic mechanism of this highly prevalent disease is still unclear. At present, there is no effective treatment available for disease improvement. In the future, selective inhibition of MMPs, the key enzymes, may become an effective therapeutic approach. Focusing on the pathogenic effects of MMPs in OA, we herein reviewed the latest findings on the role of MMPs in the occurrence and progression of OA.

 

Keywords: Matrix metalloproteinases, Osteoarthritis, MMP-13

 

Full Text:

PDF


References


FERNANDEZ-PATRON C， KASSIRI Z， LEUNG D. Modulation of systemic metabolism by MMP-2: from MMP-2 deficiency in mice to MMP-2 deficiency in patients. Compr Physiol，2016，6(4): 1935–1949. doi: 10.1002/cphy.c160010.

ALAMGEER， HASANU H， UTTRA A M， et al. Phytochemicals targeting matrix metalloproteinases regulating tissue degradation in inflammation and rheumatoid arthritis. Phytomedicine，2020，66: 153134. doi: 10.1016/j.phymed.2019.153134.

OPDENAKKER G ， Van DAMME J， VRANCKX J J. Immunomodulation as rescue for chronic atonic skin wounds. Trends Immunol，2018，39(4): 341–354. doi: 10.1016/j.it.2018.01.010.

ALASEEM A， ALHAZZANI K， DONDAPATI P， et al. Matrix metalloproteinases: a challenging paradigm of cancer management. Semin Cancer Biol，2019，56: 100–115. doi: 10.1016/j.semcancer.2017.11.008.

CABRAL-PACHECO G A， GARZA-VELOZ I， CASTRUITA-DE LA ROSA C， et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci，2020，21(24): 9739. doi: 10. 3390/ijms21249739.

MEHANA E E， KHAFAGA A F， El-BLEHI S S. The role of matrix metalloproteinases in osteoarthritis pathogenesis: an updated review. Life Sci，2019，234: 116786. doi: 10.1016/j.lfs.2019.116786.

MALEMUD C J. Matrix metalloproteinases and synovial joint pathology. Prog Mol Biol Transl Sci，2017，148: 305–325. doi: 10.1016/bs.pmbts.2017. 03.003.

HU Q， ECKER M. Overview of MMP-13 as a promising target for the treatment of osteoarthritis. Int J Mol Sci，2021，22(4): 1742. doi: 10.3390/ijms22041742.

SLOVACEK H， KHANNA R， POREDOS P， et al. Interrelationship of osteopontin, MMP-9 and ADAMTS4 in patients with osteoarthritis undergoing total joint arthroplasty. Clin Appl Thromb Hemost，2020，26: 1076029620964864. doi: 10.1177/1076029620964864.

SAFIRI S， KOLAHI A A， SMITH E， et al. Global, regional and national burden of osteoarthritis 1990–2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis，2020，79(6): 819–828. doi: 10.1136/annrheumdis-2019-216515.

Van Den BOSCH M H J. Osteoarthritis year in review 2020: biology. Osteoarthritis Cartilage，2021，29(2): 143–150. doi: 10.1016/j.joca.2020.10. 006.

PLSIKOVA MATEJOVA J， SPAKOVA T， HARVANOVA D， et al. A preliminary study of combined detection of COMP, TIMP-1, and MMP-3 in synovial fluid: potential indicators of osteoarthritis progression. Cartilage，2021，13(Suppl 2): 1421S–1430S. doi: 10.1177/19476035 20946385.

BERENBAUM F， WALLACE I J， LIEBERMAN D E， et al. Modern-day environmental factors in the pathogenesis of osteoarthritis. Nat Rev Rheumatol，2018，14(11): 674–681. doi: 10.1038/s41584-018-0073-x.

HOSGOR H. The relationship between temporomandibular joint effusion and pain in patients with internal derangement. J Craniomaxillofac Surg， 2019，47(6): 940–944. doi: 10.1016/j.jcms.2019.03.010.

ZHANG S， TEO K Y W， CHUAH S J， et al. MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis. Biomaterials，2019，200: 35–47. doi: 10. 1016/j.biomaterials.2019.02.006.

YANG H， WEN Y， ZHANG M， et al. MTORC1 coordinates the autophagy and apoptosis signaling in articular chondrocytes in osteoarthritic temporomandibular joint. Autophagy，2020，16(2): 271–288. doi: 10.1080/15548627.2019.1606647.

UKITA M， MATSUSHITA K， TAMURA M， et al. Histone H3K9 methylation is involved in temporomandibular joint osteoarthritis. Int J Mol Med，2020，45(2): 607–614. doi: 10.3892/ijmm.2019.4446.

YU J， MURSU E， TYPPÖ M， et al. MMP-3 and MMP-8 in rat mandibular condylar cartilage associated with dietary loading, estrogen level, and aging. Arch Oral Biol，2019，97: 238–244. doi: 10.1016/j. archoralbio.2018.10.037.

LIAN C， WANG X， QIU X， et al. Collagen type Ⅱ suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin β1-SMAD1 interaction. Bone Res，2019，7: 8. doi: 10.1038/s41413-019-0046-y.

HWANG I Y， YOUM Y S， CHO S D， et al. Synovial fluid levels of TWEAK and matrix metalloproteinase 1 in patients with osteoarthritis, and associations with disease severity. J Orthop Surg (Hong Kong)，2018， 26(1): 2309499018760112. doi: 10.1177/2309499018760112.

GENG R， XU Y， HU W， et al. The association between MMP-1 gene rs1799750 polymorphism and knee osteoarthritis risk. Biosci Rep，2018， 38(5): BSR20181257. doi: 10.1042/BSR20181257.

HARADEN C A， HUEBNER J L， HSUEH M F， et al. Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation. Arthritis Res Ther，2019，21(1): 146. doi: 10.1186/s13075-019-1923-x.

ZHANG Q W. Association of the matrix metalloproteinase-3 polymorphisms rs679620 and rs3025058 with ischemic stroke risk: a meta-analysis. Neuropsychiatr Dis Treat，2018，14: 419–427. doi: 10.2147/NDT.S152256.

NIE G， WEN X， LIANG X， et al. Additional evidence supports association of common genetic variants in MMP3 and TIMP2 with increased risk of chronic Achilles tendinopathy susceptibility. J Sci Med Sport，2019，22(10): 1074–1078. doi: 10.1016/j.jsams.2019.05.021.

BRIŠKI N， VRGOČ G， KNJAZ D， et al. Association of the matrix metalloproteinase 3 (MMP3) single nucleotide polymorphisms with tendinopathies: case-control study in high-level athletes. Int Orthop， 2021，45(5): 1163–1168. doi: 10.1007/s00264-020-04684-w.


Refbacks

  • There are currently no refbacks.